Literature DB >> 28556301

Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease.

J Carlos Flores-González1, Ana Estalella-Mendoza1, Alfonso M Lechuga-Sancho2, Arturo Hernández-González1, Fernando Rubio-Quiñones1, Patricia Rodríguez-Campoy1, Mónica Saldaña-Valderas3.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Dexmedetomidine (DEX) has been reported to be safe in paediatric patients. CASE DESCRIPTION: We present the case of a girl without heart disease admitted at our PICU due to an influenza A acute respiratory distress syndrome, who suffered a paroxysmal supraventricular tachycardia (PSVT) twelve hours after DEX progressive withdrawal was completed. WHAT IS NEW AND
CONCLUSION: This is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute respiratory distress syndrome; children; dexmedetomidine; influenza A; paroxysmal supraventricular tachycardia; withdrawal

Mesh:

Substances:

Year:  2017        PMID: 28556301     DOI: 10.1111/jcpt.12564

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  1 in total

1.  Clonidine for the Treatment of Agitation After Dexmedetomidine Discontinuation in Pediatric Patients: A Retrospective Cohort Study.

Authors:  Thao L Nguyen; Weng Man Lam; Hillary Orr; Brian Gulbis; Riza Mauricio; Eric Tom; Vinai M Modem; Alvaro Coronado-Munoz
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.